J. De Crée

Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist

A. Van de Water, Wim Janssens, J. Van Neuten et al. · Journal of Cardiovascular Pharmacology · 1988 · 199 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +21

Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients

Schlomo Staszewski, Veronica Miller, S. Rehmet et al. · AIDS · 1996 · 93 citations

Unchanged levels of interleukins, neopterin, interferon-γ and tumor necrosis factor-α in cerebrospinal fluid of patients with dementia of the Alzheimer type

S. Engelborghs, M. De Brabander, J. De Crée et al. · Neurochemistry International · 1999 · 70 citations

Neurodegenerative Diseases, Alzheimer Type, Alzheimer's Disease +14

Haemodynamic effects in man during exercise of a single oral dose of narbivolol (R 67555), a new beta‐1‐adrenoceptor blocking agent: A comparative study with atenolol, pindolol, and propranolol

J. De Crée, H. Geukens, J. Leempoels et al. · Drug Development Research · 1986 · 68 citations

Hypertension, R 67555, Cardiometabolic Risk +27

The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients

J. De Crée, J. Leempoels, W. De Cock et al. · Angiology · 1981 · 58 citations